New Insights Into Molecular Mechanisms of Diabetic Kidney Disease

被引:152
作者
Badal, Shawn S. [1 ]
Danesh, Farhad R. [1 ,2 ]
机构
[1] Baylor Coll Med, Interdept Grad Program Translat Biol & Mol Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Nephrol Sect, Div Internal Med, Houston, TX 77030 USA
关键词
End-stage renal disease (ESRD); diabetes mellitus; diabetic kidney disease; pathogenesis; ENDOTHELIAL GROWTH-FACTOR; VASCULAR-PERMEABILITY FACTOR; MITOCHONDRIAL SUPEROXIDE-PRODUCTION; HISTONE LYSINE METHYLATION; GLOMERULAR MESANGIAL CELLS; TO-MESENCHYMAL TRANSITION; NADPH OXIDASE COMPONENTS; COA REDUCTASE INHIBITORS; SERINE-THREONINE KINASE; TGF-BETA;
D O I
10.1053/j.ajkd.2013.10.047
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
100201 [内科学]; 100221 [泌尿外科学];
摘要
Diabetic kidney disease remains a major microvascular complication of diabetes and the most common cause of chronic kidney failure requiring dialysis in the United States. Medical advances over the past century have substantially improved the management of diabetes mellitus and thereby have increased patient survival. However, current standards of care reduce but do not eliminate the risk of diabetic kidney disease, and further studies are warranted to define new strategies for reducing the risk of diabetic kidney disease. In this review, we highlight some of the novel and established molecular mechanisms that contribute to the development of the disease and its outcomes. In particular, we discuss recent advances in our understanding of the molecular mechanisms implicated in the pathogenesis and progression of diabetic kidney disease, with special emphasis on the mitochondrial oxidative stress and microRNA targets. Additionally, candidate genes associated with susceptibility to diabetic kidney disease and alterations in various cytokines, chemokines, and growth factors are addressed briefly. (C) 2014 by the National Kidney Foundation, Inc.
引用
收藏
页码:S63 / S83
页数:21
相关论文
共 235 条
[1]
Type IV collagen is transcriptionally regulated by Smad1 under advanced glycation end product (AGE) stimulation [J].
Abe, H ;
Matsubara, T ;
Iehara, N ;
Nagai, K ;
Takahashi, T ;
Arai, H ;
Kita, T ;
Doi, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (14) :14201-14206
[2]
INCREASED VASCULAR ENDOTHELIAL GROWTH-FACTOR LEVELS IN THE VITREOUS OF EYES WITH PROLIFERATIVE DIABETIC-RETINOPATHY [J].
ADAMIS, AP ;
MILLER, JW ;
BERNAL, MT ;
DAMICO, DJ ;
FOLKMAN, J ;
YEO, TK ;
YEO, KT .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1994, 118 (04) :445-450
[3]
SUPPRESSION OF RETINAL NEOVASCULARIZATION IN-VIVO BY INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) USING SOLUBLE VEGF-RECEPTOR CHIMERIC PROTEINS [J].
AIELLO, LP ;
PIERCE, EA ;
FOLEY, ED ;
TAKAGI, H ;
CHEN, H ;
RIDDLE, L ;
FERRARA, N ;
KING, GL ;
SMITH, LEH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10457-10461
[4]
Identification of a putative target for Rho as the serine-threonine kinase protein kinase N [J].
Amano, M ;
Mukai, H ;
Ono, Y ;
Chihara, K ;
Matsui, T ;
Hamajima, Y ;
Okawa, K ;
Iwamatsu, A ;
Kaibuchi, K .
SCIENCE, 1996, 271 (5249) :648-650
[5]
Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase [J].
Amano, M ;
Chihara, K ;
Kimura, K ;
Fukata, Y ;
Nakamura, N ;
Matsuura, Y ;
Kaibuchi, K .
SCIENCE, 1997, 275 (5304) :1308-1311
[6]
The functions of animal microRNAs [J].
Ambros, V .
NATURE, 2004, 431 (7006) :350-355
[7]
AMER DIABET ASSOC, 1993, DIABETES, V42, P1555
[8]
PATHOGENESIS OF DIABETIC GLOMERULOPATHY - HEMODYNAMIC CONSIDERATIONS [J].
ANDERSON, S ;
BRENNER, BM .
DIABETES-METABOLISM REVIEWS, 1988, 4 (02) :163-177
[9]
Mitochondrial metabolism of reactive oxygen species [J].
Andreyev, AI ;
Kushnareva, YE ;
Starkov, AA .
BIOCHEMISTRY-MOSCOW, 2005, 70 (02) :200-214
[10]
[Anonymous], MIRBASE MICRORNA DAT